ATC Group: V08A X-ray contrast media, iodinated

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V08A in the ATC hierarchy

Level Code Title
1 V Various
2 V08 Contrast media
3 V08A X-ray contrast media, iodinated

Group V08A contents

Code Title
V08AA Watersoluble, nephrotropic, high osmolar X-ray contrast media
V08AB Watersoluble, nephrotropic, low osmolar X-ray contrast media
V08AC Watersoluble, hepatotropic X-ray contrast media
V08AD Non-watersoluble X-ray contrast media

Active ingredients in V08A

Active Ingredient

Iobitriol is a urographic and angiographic water-soluble nonionic contrast agent.

Iohexol is an effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.

Iopamidol is contrast medium belonging to the new generation of non-ionic compound whose solubility is due to the presence of hydrophilic substitutes in the molecule. This results in a solution of low osmollity when compared with ionic media.

The contrast-giving substance in the iopromide formulations is iopromide, a non-ionic water-soluble derivative of triiodinated isophthalic acid in which the firmly bound iodine absorbs the X-rays. Injection of iopromide opacifies those vessels or body cavities in the path of flow of the contrast agent, permitting radio-graphic visualization of the internal structures until significant dilution occurs.

Iotalamic acid is intended for use as a diagnostic radiopaque medium. It is used in excretory urography, cerebral angiography, peripheral arteriography, venography, arthrography, direct cholangiography, endoscopic retrograde cholangiopancreatography, contrast enhancement of computed tomographic brain images, cranial computerized angiotomography, intravenous digital subtraction angiography and arterial digital subtraction angiography.

Ioversol is a non-ionic X-ray contrast medium. Intravascular injection of ioversol opacifies those vessels in the path of the flow of the contrast medium, permitting radiographic visualisation of the internal structures until significant haemodilution occurs.

Related product monographs

Document Type Information Source  
 CONRAY Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 CYSTO-CONRAY II Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 GASTROGRAFIN Gastroenteral solution MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 GASTROMIRO Solution for oral or rectal administration MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 IOMERON Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 ISOVUE 200/250/300/370 Solution for injection MPI, US: SPL/Old FDA, National Drug Code (US)
 NIOPAM Solution for injection MPI, EU: SmPC Medicines & Healthcare Products Regulatory Agency (GB)
 OMNIPAQUE Solution MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 OPTIRAY Solution for injection or infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 ULTRAVIST Solution for injection MPI, EU: SmPC Health Products Regulatory Authority (IE)
 UROGRAFIN Solution for infusion MPI, EU: SmPC Health Products Regulatory Authority (IE)
 VISIPAQUE Solution for injection MPI, EU: SmPC Medicines and Medical Devices Safety Authority (NZ)
 XENETIX Solution for injection MPI, EU: SmPC